{
    "id": "9124323",
    "text": "Bivatuzumab mertansine is a combination of bivatuzumab, a humanized monoclonal antibody, and mertansine, a cytotoxic agent. It is designed for the treatment of squamous cell carcinoma. == References == Category:Monoclonal antibodies for tumors Category:Experimental cancer drugs ",
    "title": "Bivatuzumab mertansine"
}